ROSE LifeScience announced that it will add HEXO‘s (HEXO) Quebec portfolio to ROSE’s industry leading commercialization and distribution services business. Headquartered in Gatineau, Quebec, HEXO delivers premium cannabis experiences that inspire customer loyalty, from recreational to therapeutic products. HEXO’s products balance THC with CBD, terpene levels and flavonoids, to create high-quality, clean, consistent customer favourites. HEXO’s state-of-the-art facilities in Masson-Angers, Quebec are purpose-built and engineered to provide exceptional capacity and streamlined operations, developing innovative products to serve the cannabis market in Quebec, across Canada and globally. ROSE’s commercialization and distribution expertise will help to position HEXO’s Quebec portfolio for further expansion in the province, complementing ROSE’s relationship with Tilray Brands, (TLRY), a long-standing ROSE commercialization and distribution partner.
Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
Published first on TheFly
See the top stocks recommended by analysts >>
Read More on HEXO:
- Tilray price target lowered to $5 from $9 at TD Cowen
- Tilray to acquire all issued, outstanding common shares of Hexo
- Hexo jumps 34% after report on Tilray buyout deal
- Tilray to buy Hexo in deal worth about $250M, Bloomberg says
- Hexo price target lowered to C$1.80 from C$2.80 at Canaccord
Looking for a trading platform? Check out TipRanks' Best Online Brokers guide, and find the ideal broker for your trades.
Report an Issue